Comparative Bioavailability of Isoniazid, Rifampin, and Pyrazinamide Administered in Free Combination and in a Fixed Triple Formulation Designed for Daily Use in Antituberculosis Chemotherapy: II. Two-Month, Daily Administration Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative Bioavailability of Isoniazid, Rifampin, and Pyrazinamide Administered in Free Combination and in a Fixed Triple Formulation Designed for Daily Use in Antituberculosis Chemotherapy: II. Two-Month, Daily Administration Study

Published:1988-10 Issue:4 Volume:138 Page:886-890
ISSN:0003-0805
Container-title:American Review of Respiratory Disease
language:en
Short-container-title:Am Rev Respir Dis

Author:

Acocella Gianni,Nonis Atanasio,Perna Giangostino,Patane Emanuele,Gialdroni-Grassi Giuliana,Grassi Carlo

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Pharmacology Perspective on Simultaneous Tuberculosis and Hepatitis C Treatment;Antimicrobial Agents and Chemotherapy;2019-12

2. Individualised dosing algorithm and personalised treatment of high‐dose rifampicin for tuberculosis;British Journal of Clinical Pharmacology;2019-07-25

3. Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting;Journal of Antimicrobial Chemotherapy;2018-08-14

4. Pyrazinamide pharmacokinetics and efficacy in adults and children;Tuberculosis;2012-01

5. Oral Testosterone With and Without Concomitant Inhibition of 5α-Reductase by Dutasteride in Hypogonadal Men for 28 Days;Journal of Urology;2011-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP